Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intepirdine and Donepezil in Mild to Moderate Alzheimer's Disease
NCT00348192Phase 2Completed
- Sponsor
- GSK
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of intepirdine in Alzheimer's disease (AD), sponsored by GSK. Started May 2006; status: completed.
02
Drugs
intepirdine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00348192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348192.